Catalyst Wire Dossier Catalyst Wire Dossier

PegIntron

pegylated interferon alfa-2b · Merck & Co.
Drug timelines are a Plus or Pro feature.

57 regulatory and trial events tracked for PegIntron, covering 2006-08-15 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

See pricing